Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Patient-Centered Research Report Sent To Congress Outlining Research Priorities
Recommendations for how the HHS Office of the Secretary will spend $400 million in funds for patient-centered research, also known as comparative effectiveness research, were released by Federal Coordinating Council for Comparative Effectiveness Research (CER). The report, mandated by the American Recovery and Reinvestment Act, is designed to help the HHS Secretary and lawmakers improve the quality of care for patients, and provide patients and doctors the best information possible to make decisions about health care.

Buy lamisil to treat nail fungus.
Vaginal Infections 'symptom Sorter' Launches To Help Women Get Diagnosed And Treated
Three quarters (75%) of women with BV (Bacterial Vaginosis) admit the condition has prevented them from getting intimate with their partner, according to a new survey by Balance ActivTM Vaginal Gel.1 Sufferers reveal BV affects their personal relationships more than any other aspect of their lives, with one in ten sufferers resorting to ending relationships as a result of the embarrassing symptoms.1
News of the day
Global Confirmed Swine Flu Cases Nears 10,000
According to WHO (World Health Organization), the total number of confirmed swine flu A(H1N1) cases of human infections stands at 9,830, including 79 deaths. The numbers of confirmed cases are rising by approximately 1,000 per day, says WHO. Japan has seen confirmed cases rise sharply over the last few days.
Sexual Health

Transdermal Drug Delivery For CNS Conditions Expected To Exceed $1 Billion By 2012

While often overshadowed in the public consciousness by cancer and heart disease, recent trends in certain pathologies of the central nervous system are becoming equally challenging for clinicians and researchers. Growth in the incidence of a number of neurological conditions such as Alzheimer"s and Parkinson"s has captured the concerns of healthcare professionals, and reached the public at large through personal experience and the media. While some of the increase in the incidence of non-neoplastic CNS disorders can be traced to population growth and demographic trends, particularly the aging of populations in developed geographic regions, often the specific causes prove to be elusive. And while patient mortality varies widely within this group of conditions, the morbidity and quality-of-life issues for patients and their families with chronic or progressive CNS disorders are typically quite dramatic. "The intractable nature of these diseases dictates the need for continuous drug intervention," explains George Perros, Managing Director at Applied Data Research. "But the treatment picture is complicated by the fact that most of these ailments compromise the cognitive and/or motor skills of patients, making ongoing self-administration unreliable and raising patient safety concerns." Attempting to address this growing need, drug developers are increasingly turning to transdermal formulations of CNS drugs. Because it has the potential to improve drug therapy compliance and safety, transdermal delivery addresses key therapeutic healthcare issues. According to a comprehensive assessment by Applied Data Research, the ability of transdermal CNS therapeutics to respond to the growing unmet need for patient-friendly administration has positioned this segment for healthy double-digit growth through 2012, with the total value of transdermal CNS drug products exceeding $1 billion in 2012. These findings are contained in a comprehensive report prepared and written by Applied Data Research. More information is available at http://www.applieddata.org. Applied Data Research


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009